Cwm, LLC Iovance Biotherapeutics, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 4,484 shares of IOVA stock, worth $10,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,484

Previous 4,355 2.96%

Holding current value

$10,402

Previous $7,000 42.86%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$1.7 - $3.97 $219 - $512	129 Added 2.96%	4,484 $10,000
Q2 2025 Jul 25, 2025	SELL	$1.66 - $3.61 $2,219 - $4,826	-1,337 Reduced 23.49%	4,355 $7,000
Q1 2025 May 01, 2025	BUY	$3.33 - $7.79 $16,686 - $39,035	5,011 Added 735.83%	5,692 $19,000
Q4 2024 Feb 04, 2025	SELL	$7.17 - $12.28 $286 - $491	-40 Reduced 5.55%	681 $5,000
Q3 2024 Oct 08, 2024	BUY	$7.28 - $11.9 $1,011 - $1,654	139 Added 23.88%	721 $7,000
Q2 2024 Jul 09, 2024	BUY	$7.78 - $14.19 $140 - $255	18 Added 3.19%	582 $5,000
Q1 2024 Apr 05, 2024	BUY	$7.59 - $17.47 $30 - $69	4 Added 0.71%	564 $8,000
Q4 2023 Feb 01, 2024	BUY	$3.3 - $8.89 $1,395 - $3,760	423 Added 308.76%	560 $5,000
Q3 2023 Oct 11, 2023	SELL	$4.44 - $8.79 $257 - $509	-58 Reduced 29.74%	137 $1,000
Q2 2023 Aug 03, 2023	BUY	$5.36 - $9.06 $578 - $978	108 Added 124.14%	195 $1,000
Q1 2023 Apr 28, 2023	BUY	$5.53 - $8.22 $176 - $263	32 Added 58.18%	87 $1,000
Q4 2022 Feb 01, 2023	SELL	$5.62 - $10.0 $6,266 - $11,150	-1,115 Reduced 95.3%	55 $0
Q3 2022 Oct 27, 2022	SELL	$9.53 - $13.11 $4,622 - $6,358	-485 Reduced 29.31%	1,170 $11,000
Q2 2022 Jul 28, 2022	BUY	$6.38 - $18.33 $10,450 - $30,024	1,638 Added 9635.29%	1,655 $18,000
Q1 2022 Apr 21, 2022	BUY	$12.38 - $19.1 $61 - $95	5 Added 41.67%	17 $0
Q4 2021 Jan 31, 2022	BUY	$16.55 - $27.63 $198 - $331	12 New	12 $0

Others Institutions Holding IOVA

# of Institutions

298

Shares Held

234M

Call Options Held

1.14M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $366M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account